| 04-12-2022 | Long-term performance, Expectations |
| 27-11-2022 | Few Tips to achieve Asymmetry |
| 12-11-2022 | doubt on Current Market Rally’s Sustainability |
Sign-up for our Contents
| 02 October 2022 | Newsletter – 2 October 2022 |
| 25 Sep 2022 | Fed raises Rates, Rupee Tumbles |
| 18 Sep 2022 | Banking Sector Shines |
| 28 August 2022 | ‘There are no Rules’ is the only Rule there is |
| 25 July 2022 | Despite Market Rally Trend Remains Negative |
| 18 July 2022 | Time to Invest |
Sign-up for our Contents
| 26 June 2022 | Signs of Revival in Auto sector? |
| 19 June 2022 | Fed Interest Rate Hike Triggers Market Carnage |
| 12 June 2022 | Dividends can make you Rich |
| 5 June 2022 | Market this week – 5 June 2022 |
| 29 May 2022 | Divergent Performance |
| 22 May 2022 | Endurance is the need of the hour |
| 8 May 2022 | The RBI gut-punch |
| 1 May 2022 | The Twin Catalysts |
| 17 April 2022 | The Ambiguity of High Inflation |
| 10 April 2022 | RBI’s Pivot Of Focus From Growth To Inflation |
| 27 March 2022 | Crude Oil Price Spike Exacerbates Indian Equity Prospect |
| 20 March 2022 | Valuation moderates, while Headwinds persist |
| 13 Feb 2022 | RBI prioritizes growth over inflation, Mixed Quarterly Results |
| 6 Feb 2022 | Market gains on budget announcements |
January 2022
Tata Elxsi shines, While IT bleeds this week
18,000 reclaimed. Wow! That was so fast!
Will The Light Shine On Pharma Stocks?